| pubmed-article:17347483 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17347483 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:17347483 | lifeskim:mentions | umls-concept:C0032173 | lld:lifeskim |
| pubmed-article:17347483 | lifeskim:mentions | umls-concept:C0017968 | lld:lifeskim |
| pubmed-article:17347483 | lifeskim:mentions | umls-concept:C0680242 | lld:lifeskim |
| pubmed-article:17347483 | lifeskim:mentions | umls-concept:C1701268 | lld:lifeskim |
| pubmed-article:17347483 | lifeskim:mentions | umls-concept:C0332291 | lld:lifeskim |
| pubmed-article:17347483 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:17347483 | pubmed:dateCreated | 2007-4-19 | lld:pubmed |
| pubmed-article:17347483 | pubmed:abstractText | Thrombus formation after atherosclerotic plaque rupture critically involves the platelet collagen receptor glycoprotein (GP) VI. We investigated the impact of EXP3179, an active metabolite of the angiotensin II type 1 (AT1)-receptor antagonist Losartan (LOS) on GPVI-dependent platelet activation. | lld:pubmed |
| pubmed-article:17347483 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17347483 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17347483 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17347483 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17347483 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17347483 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17347483 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17347483 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17347483 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17347483 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17347483 | pubmed:month | May | lld:pubmed |
| pubmed-article:17347483 | pubmed:issn | 1524-4636 | lld:pubmed |
| pubmed-article:17347483 | pubmed:author | pubmed-author:SchiefferBern... | lld:pubmed |
| pubmed-article:17347483 | pubmed:author | pubmed-author:KremmerElisab... | lld:pubmed |
| pubmed-article:17347483 | pubmed:author | pubmed-author:GawazMeinradM | lld:pubmed |
| pubmed-article:17347483 | pubmed:author | pubmed-author:LuchtefeldMar... | lld:pubmed |
| pubmed-article:17347483 | pubmed:author | pubmed-author:SchmidtBorisB | lld:pubmed |
| pubmed-article:17347483 | pubmed:author | pubmed-author:MassbergSteff... | lld:pubmed |
| pubmed-article:17347483 | pubmed:author | pubmed-author:KonradIldikoI | lld:pubmed |
| pubmed-article:17347483 | pubmed:author | pubmed-author:SchulzChristi... | lld:pubmed |
| pubmed-article:17347483 | pubmed:author | pubmed-author:UmbreenSumair... | lld:pubmed |
| pubmed-article:17347483 | pubmed:author | pubmed-author:GrothusenChri... | lld:pubmed |
| pubmed-article:17347483 | pubmed:author | pubmed-author:StellosKonsta... | lld:pubmed |
| pubmed-article:17347483 | pubmed:author | pubmed-author:TeebkenOmkeO | lld:pubmed |
| pubmed-article:17347483 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17347483 | pubmed:volume | 27 | lld:pubmed |
| pubmed-article:17347483 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17347483 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17347483 | pubmed:pagination | 1184-90 | lld:pubmed |
| pubmed-article:17347483 | pubmed:dateRevised | 2008-6-10 | lld:pubmed |
| pubmed-article:17347483 | pubmed:meshHeading | pubmed-meshheading:17347483... | lld:pubmed |
| pubmed-article:17347483 | pubmed:meshHeading | pubmed-meshheading:17347483... | lld:pubmed |
| pubmed-article:17347483 | pubmed:meshHeading | pubmed-meshheading:17347483... | lld:pubmed |
| pubmed-article:17347483 | pubmed:meshHeading | pubmed-meshheading:17347483... | lld:pubmed |
| pubmed-article:17347483 | pubmed:meshHeading | pubmed-meshheading:17347483... | lld:pubmed |
| pubmed-article:17347483 | pubmed:meshHeading | pubmed-meshheading:17347483... | lld:pubmed |
| pubmed-article:17347483 | pubmed:meshHeading | pubmed-meshheading:17347483... | lld:pubmed |
| pubmed-article:17347483 | pubmed:meshHeading | pubmed-meshheading:17347483... | lld:pubmed |
| pubmed-article:17347483 | pubmed:meshHeading | pubmed-meshheading:17347483... | lld:pubmed |
| pubmed-article:17347483 | pubmed:meshHeading | pubmed-meshheading:17347483... | lld:pubmed |
| pubmed-article:17347483 | pubmed:meshHeading | pubmed-meshheading:17347483... | lld:pubmed |
| pubmed-article:17347483 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17347483 | pubmed:articleTitle | EXP3179 inhibits collagen-dependent platelet activation via glycoprotein receptor-VI independent of AT1-receptor antagonism: potential impact on atherothrombosis. | lld:pubmed |
| pubmed-article:17347483 | pubmed:affiliation | Abt. fuer Kardiologie und Angiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. | lld:pubmed |
| pubmed-article:17347483 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17347483 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17347483 | lld:pubmed |
